Yves Collette
Collette, Yves, 19-..
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 190591403 (Personal)
Permalink: http://viaf.org/viaf/190591403
Preferred Forms
-
100 1 _
‡a
Collette, Yves
‡d
19-.
-
100 1 _
‡a
Collette, Yves,
‡d
19-..
-
100 0 _
‡a
Yves Collette
4xx's: Alternate Name Forms (3)
Works
| Title | Sources |
|---|---|
| 1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein |
|
| Active Transcription of the HumanFASL/CD95L/TNFSF6Promoter Region in T Lymphocytes Involves Chromatin Remodeling |
|
| Altered splicing in hematological malignancies reveals a tissue-specific translational block of the Src-family tyrosine kinase fyn brain isoform expression |
|
| Alternative splicing modulates autoinhibition and SH3 accessibility in the Src kinase Fyn. |
|
| Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities |
|
| Anti-leukemia activity of MS-275 histone deacetylase inhibitor implicates 4-1BBL/4-1BB immunomodulatory functions |
|
| ASSISTANCE RESPIRATOIRE EXTRA-CORPORELLE DANS LE TRAITEMENT DU SYNDROME DE DETRESSE RESPIRATOIRE AIGUE DE L'ADULTE ; EXPERIENCE DU SERVICE DE REANIMATION MEDICALE DU C.H.U. DE BESANCON, A PROPOS DE NEUF CAS |
|
| BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia |
|
| Cancer et agents pathogènes |
|
| CD28 can promote T cell survival through a phosphatidylinositol 3-kinase-independent mechanism |
|
| CD95L cell surface cleavage triggers a prometastatic signaling pathway in triple-negative breast cancer |
|
| Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism |
|
| Le complexe erBB2/MEMO, une cible thérapeutique dans le cadre du cancer du sein |
|
| Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392. |
|
| Coxiella burnetii avoids macrophage phagocytosis by interfering with spatial distribution of complement receptor 3. |
|
| Cutting edge: recruitment of the ancestral fyn gene during emergence of the adaptive immune system |
|
| Design of N-substituted amino caproic hydroxamic acid histone deacetylase inhibitors reveal an essential role for cap atomic composition |
|
| The distinct capacity of Fyn and Lck to phosphorylate Sam68 in T cells is essentially governed by SH3/SH2-catalytic domain linker interactions |
|
| Distinct regulation of T-cell death by CD28 depending on both its aggregation and T-cell receptor triggering: a role for Fas-FasL. |
|
| Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia |
|
| Dynamic recruitment of the adaptor protein LAT: LAT exists in two distinct intracellular pools and controls its own recruitment |
|
| Evidence for intact CD28 signaling in T cell hyporesponsiveness induced by the HIV-1nef gene |
|
| Evidences for ubiquitination and intracellular trafficking of LAT, the linker of activated T cells |
|
| Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins |
|
| Frontline: Characterization of BT3 molecules belonging to the B7 family expressed on immune cells |
|
| Full peptide synthesis, purification, and characterization of six Tat variants. Differences observed between HIV-1 isolates from Africa and other continents |
|
| Functional interaction of RasGAP-binding proteins Dok-1 and Dok-2 with the Tec protein tyrosine kinase |
|
| The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression |
|
| Histone méthyltransférases |
|
| The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism. |
|
| Human immunodeficiency virus type 1 Nef protein sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway. |
|
| Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts |
|
| Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer |
|
| Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities. |
|
| Importance du repliement intramoléculaire dans la fonction biologique et l'évolution des Src-kinases |
|
| An improved synthesis of an umbelliferyl 5-thioxylopyranoside, precursor of the antithrombotic drug Iliparcil |
|
| Inhibition of ErbB2/HER2-MEMO complex: a new therapy in breast cancer. |
|
| Integrated Strategy for Lead Optimization Based on Fragment Growing: The Diversity-Oriented-Target-Focused-Synthesis Approach |
|
| Interaction with simian Hck tyrosine kinase reveals convergent evolution of the Nef protein from simian and human immunodeficiency viruses despite differential molecular surface usage |
|
| JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid Leukemia. |
|
| Mechanisms regulating expression of the tumor necrosis factor-related light gene. Role of calcium-signaling pathway in the transcriptional control |
|
| Modified cap group suberoylanilide hydroxamic acid histone deacetylase inhibitor derivatives reveal improved selective antileukemic activity. |
|
| Modulation pharmacologique des modifications épigénétiques dans les cancers |
|
| Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer |
|
| Non-receptor protein tyrosine kinases as immune targets of viruses |
|
| A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells |
|
| Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: a model study |
|
| Personalized preclinical study of a rare t(1;9)(q24;q34) “Ph-like” translocation and perspectives of optimization of bad prognosis B-ALL treatments. |
|
| Physical and functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects. |
|
| Une plateforme de médecine de précision fonctionnelle dans les leucémies aiguës myéloïdes. |
|
| Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha |
|
| Primary B-CLL resistance to NK cell cytotoxicity can be overcome in vitro and in vivo by priming NK cells and monoclonal antibody therapy |
|
| The Primate Lentivirus-Encoded Nef Protein Can Regulate Several Steps of the Viral Replication Cycle |
|
| Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy |
|
| Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein |
|
| Protein-Protein Interaction Inhibition (2P2I)-Oriented Chemical Library Accelerates Hit Discovery |
|
| Régulation de la signalisation de Src par son domaine N-terminal intrinsèquement désordonné |
|
| Régulation transcriptionnelle différentielle de la superfamille du TNF : rôle de la chromatine et contrôle pharmacologique à visée thérapeutique |
|
| Régulations intramoléculaires et intermoléculaires des membres de la famille Src : implication des interactions du domaine SH3 avec l'interdomaine |
|
| The role of HIV1 Nef in T-cell activation: Nef impairs induction of Th1 cytokines and interacts with the Src family tyrosine kinase Lck. |
|
| Role of ICAM-3 in the initial interaction of T lymphocytes and APCs |
|
| The role of p21ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7-1, activates p21ras |
|
| Role of Tec kinase in nuclear factor of activated T cells signaling |
|
| Signaling-dependent immobilization of acylated proteins in the inner monolayer of the plasma membrane |
|
| Significance of intramolecular folding for Src-kinases biological function and role in evolution. |
|
| Similarity between Nef of primate lentiviruses and p15E of murine and feline leukaemia viruses. |
|
| A simplified, 96-well-adapted, ATP luminescence-based motility assay |
|
| A specific protein disorder catalyzer of HIV-1 Nef |
|
| Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 Nef gene-induced expression. |
|
| Stereoselective ring contraction of 2,5-diketopiperazines: An innovative approach to the synthesis of promising bioactive 5-membered scaffolds |
|
| Stereoselective synthesis of original spirolactams displaying promising folded structures. |
|
| Structural recognition mechanisms between human Src homology domain 3 (SH3) and ALG-2-interacting protein X (Alix) |
|
| Study of the dynamic of recruitment of LAT adaptor protein into the immunological synapse during T lymphocyte activation. |
|
| Study of the molecular origin of cellular response heterogeneity to TRAIL and its role in non-genetic resistance. |
|
| Study of the transcriptional regulation of the TNF-SF6 and TNF-SF14 genes. |
|
| Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies |
|
| Synergy and allostery in ligand binding by HIV-1 Nef |
|
| Targeting histone chaperones by a peptidomimetic strategy. |
|
| Tec kinases: a family with multiple roles in immunity |
|
| Therapeutic targeting of c-Myc in T-cell acute lymphoblastic leukemia, T-ALL |
|
| Towards a consensus for a role of Nef in both viral replication and immunomodulation? |
|
| Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity |
|
| Tumor selective cytotoxic action of a thiomorpholin hydroxamate inhibitor (TMI-1) in breast cancer |
|
| The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein |
|
